Schedule 13G ownership disclosure

BOLT BIOTHERAPEUTICS INC

Common Stock, par value $0.00001 per share · CUSIP: 097702203

Event date: 2026-10-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Coastlands Capital LP

    Shares: 412,416.00 · Class: 17.50%

  • Coastlands Capital Partners LP

    Shares: 412,416.00 · Class: 17.50%

  • Coastlands Capital GP LLC

    Shares: 412,416.00 · Class: 17.50%

  • Coastlands Capital LLC

    Shares: 412,416.00 · Class: 17.50%

  • Matthew D. Perry

    Shares: 412,416.00 · Class: 17.50%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-123999
Form type
SCHEDULE 13G
Filer
Coastlands Capital LP
CIK
CIK 2068530
Filed
Nov 06, 2026
Reporting period
Oct 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub